Quantcast

Latest Diabetes Stories

2014-06-16 23:01:08

The Firm is evaluating Lipitor lawsuits on behalf of individuals who allegedly developed Type 2 diabetes due to their use of the cholesterol-lowering statin. New York, NY (PRWEB) June 16, 2014 Lipitor lawsuits (http://www.thelipitorlawsuit.com/) that allege the cholesterol-lowering statin caused patients to develop Type 2 diabetes continue to mount in the federal multidistrict litigation now underway in U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports....

2014-06-16 20:22:11

AWARD-2: Once-Weekly Dulaglutide 0.75 mg Non-Inferior, 1.5 mg Superior in HbA1c Reduction from Baseline with Sustained Weight Loss and Lower Risk for Hypoglycemia SAN FRANCISCO, June 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today released detailed results from two AWARD trials that showed treatment with once-weekly dulaglutide 1.5 mg resulted in superior reductions in HbA1c from baseline compared to insulin glargine, with a lower risk for hypoglycemia.(1,2) Dulaglutide is an...

2014-06-16 18:01:02

Tonic Life Communications USA Presented at the American Diabetes Association Scientific Sessions Animas Corporation today shared encouraging results from its predictive hypoglycemia-minimizing algorithm in development. Data from a clinical feasibility study demonstrated that the algorithm was capable of helping maintain glucose above hypoglycemic levels an average of 99.1 percent of the time for the 12 participants investigated, all of whom were adults with type 1 diabetes. The study...

2014-06-16 16:25:39

Phase 3 Study Results Also Demonstrate INVOKANA® Reduces Secondary Endpoints of Body Weight and Systolic Blood Pressure RARITAN, N.J., June 16, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) today announced new results from a 104-week Phase 3 clinical study evaluating the long-term effects of INVOKANA(®) (canagliflozin) in patients aged 55 to 80 years with type 2 diabetes inadequately controlled on current antihyperglycemic therapies. The randomized double-blind...

2014-06-16 13:02:01

American Diabetes Association One study shows adolescent brains process sugar differently than adult brains; another finds evidence changes in adipose tissue begin at very young age for obese children With the increase in childhood obesity and the associated increase in type 2 diabetes among children and adolescents, there is growing interest in how children's bodies process the foods they eat and how obesity and diabetes begin to develop at early ages. Two studies presented at the...

2014-06-16 13:00:18

St. Michael's Hospital Those on canola bread diet saw both a reduction in blood glucose levels and significant reduction in LDL cholesterol Canola is Canada's oil and new research from St. Michael's Hospital suggests it should also be one of the oils of choice for people with Type 2 diabetes. Dr. David Jenkins, head of the hospital's Clinical Nutrition and Risk Factor Modification Centre, compared people with Type 2 diabetes who ate either a low glycemic index diet that included bread...

2014-06-16 12:58:06

Merck Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced results from a post-hoc analysis showing that patients with type 2 diabetes having treatment intensified with insulin glargine therapy while also being treated with JANUVIA® (sitagliptin) 100 mg once-daily had a lower incidence of nighttime (nocturnal) hypoglycemia compared to patients also receiving placebo. Results were presented at the American Diabetes Association 74th Scientific Sessions....

2014-06-16 12:47:49

Kureczka/Martin Associates Presentation at American Diabetes Association meeting by ClinMet founder Use of anti-oxidants may be ineffective or even contribute to kidney disease and other complications of diabetes, rather than helping to treat such health problems. That conclusion, based on growing unexpected findings that stimulating mitochondrial function and superoxide production results in improved markers of renal, cardiovascular and nerve dysfunction, was presented this week in a...

2014-06-16 12:45:00

Intermountain Medical Center For prediabetics, many interventions focus on lifestyle changes and weight loss, but new research on periodic fasting has identified a biological process in the body that converts bad cholesterol in fat cells to energy, thus combating diabetes risk factors. Researchers at the Intermountain Heart Institute at Intermountain Medical Center in Murray, Utah, noticed that after 10 to 12 hours of time fasting, the body starts scavenging for other sources of energy...

2014-06-16 12:29:40

GAITHERSBURG, Md., June 16, 2014 /PRNewswire/ -- The 74th Scientific Session of the American Diabetes Association (ADA) was the setting that released the initial results from the recently completed multi-center diabetic retinopathy (DR) screening clinical trial. The trial evaluated the effectiveness of RETeval based visual electrophysiology in assessing sight threatening DR as well as clinically significant macular edema (CSME) in comparison to the gold standard of dilated...


Latest Diabetes Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (3 articles) »
Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related